About US Pharma
US Pharma is an Industrial Goods & Manufacturing company. Pharmaceutical product manufacturing and contract services in India. It operates in the Industrial Goods & Manufacturing and Healthcare sectors. Its Indian entity U S Pharma (India) Private Limited reported revenue of ₹89.26 Cr. US Pharma offers products and services including Tablets and Capsules. Its focus areas include Manufacturing Services, Contract Manufacturing, Production Services and Pharmaceuticals.
Company details
US Pharma is recognized as a global leader in the pharmaceutical industry, where cost-effective medicines have been crafted and produced for over two decades. A state-of-the-art manufacturing facility is situated near Mumbai, enabling the delivery of high-quality pharmaceutical products worldwide. Products such as tablets, capsules, injectables, and liquid orals are offered, along with services like formulation development and regulatory compliance support. Innovation is emphasized to ensure accessibility of healthcare solutions across borders.
- SectorsIndustrial Goods & ManufacturingHealthcare
- Email••••••••
- Phone•••• ••••
- Website uspharma.in
- Social LinkedIn
- Legal Name Us Pharma India Pvt. Ltd
- Date of Incorporation 21 May, 2003
- Jurisdiction Mumbai, Maharashtra, India
- Indian entity revenue₹89.26 Cr
FY 2025 · +421% YoY
- Indian entity net profit₹8.02 Cr
FY 2025 · 9% margin
- Indian entity EBITDA₹10.56 Cr
FY 2025 · 12% margin
Associated legal entities of US Pharma
US Pharma operates through U S Pharma (India) Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| U S Pharma (India) Private Limited CIN U24230MH2003PTC140514 | Active | 21 May 2003 | Mumbai, Maharashtra | ₹89.3 Cr | 2 | View details |
Products & Services of US Pharma
US Pharma offers a comprehensive portfolio of products and services, including Tablets and Capsules.
Tablets are manufactured as convenient and easy-to-administer oral medications for various health applications.
Capsules are produced for precise dosage delivery in pharmaceutical treatments.
Board of directors of U S Pharma (India) Private Limited (US Pharma)
U S Pharma (India) Private Limited is the primary company behind US Pharma. The board of U S Pharma (India) Private Limited currently have 2 directors; the longest-serving is Tapan Haresh Sanghvi, appointed in 2014. 9 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Tapan Haresh Sanghvi DIN 06564350 | Director | 12 Dec 2014 | 11 yrs 10 mo | U S Pharma (India) Private Limited |
| Mansi Tapan Sanghvi DIN 07736756 | Director | 30 Sep 2020 | 6 yrs 1 mo | U S Pharma (India) Private Limited |
Financials of US Pharma
Figures of U S Pharma (India) Private Limited, the primary company behind US Pharma, for FY 2025. Revenue was ₹89.26 Cr (+421% year on year). Net profit was ₹8.02 Cr (9% margin). EBITDA was ₹10.56 Cr (12% margin). Revenue has grown at a compounded annual rate of +43% over three years and +31% over five years.
- ₹89.26 CrRevenue · FY 2025 · +421% YoY
- ₹8.02 CrNet profit · 9% margin
- ₹10.56 CrEBITDA · 12% margin
- ₹1.24 CrPaid-up capital
- +43%Revenue CAGR, 3 years
- +31%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of U S Pharma (India) Private Limited are on its company page.
Detailed financial statements for US Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of US Pharma
Websites that share an audience with US Pharma (uspharma.in).
Websites whose visitors overlap most with US Pharma. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| enaltec.com | 100% | 1.3K | #13,000,169 | View details | |
| chembondindia.com | 94% | 4.9K | #3,670,783 | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about US Pharma
The primary company behind US Pharma, U S Pharma (India) Private Limited, reported revenue of ₹89.26 Cr for FY 2025, up 421% year on year.
US Pharma is recognized as a global leader in the pharmaceutical industry, where cost-effective medicines have been crafted and produced for over two decades. A state-of-the-art manufacturing facility is situated near Mumbai, enabling the delivery of high-quality pharmaceutical products worldwide. Products such as tablets, capsules, injectables, and liquid orals are offered, along with services like formulation development and regulatory compliance support. Innovation is emphasized to ensure accessibility of healthcare solutions across borders.
US Pharma offers Tablets and Capsules.
US Pharma operates through U S Pharma (India) Private Limited.
The legal entities of US Pharma currently have 2 directors, including Tapan Haresh Sanghvi, Mansi Tapan Sanghvi.